Ex vivo expanded haematopoietic progenitor cells improve dermal wound healing by paracrine mechanisms

Experimental Dermatology

Volumn 18, Issue 5, 2009, Pages 445-453

  Templin, Christian ^a,b   Grote, Karsten ^b   Schledzewski, Kai ^c   Ghadri, Jelena Rima ^a   Schnabel, Sabine ^b   Napp, Lars Christian ^b   Schieffer, Bernhard ^b   Kurzen, Hjalmar ^c   Goerdt, Sergij ^c   Landmesser, Ulf ^a   Koenen, Wolfgang ^c   Faulhaber, Jörg ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Angiogenesis; Haematopoietic progenitor cells; Paracrine mechanisms; Wound healing

Indexed keywords

CD31 ANTIGEN; CD68 ANTIGEN; GELATINASE A; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY DENSITY; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; ENDOTHELIUM CELL; EX VIVO STUDY; FIBROBLAST; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MACROPHAGE; MALE; NONHUMAN; PARACRINE SIGNALING; PROTEIN MICROARRAY; WOUND HEALING;

3T3 CELLS; ANIMALS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL2; CULTURE MEDIA, CONDITIONED; ENDOTHELIUM, VASCULAR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATION; WOUND HEALING;

EID: 65249180572     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00809.x     Document Type: Article

References (33)

1. Yamaguchi Y, Yoshikawa K. Cutaneous wound healing: An update. J Dermatol 2001: 28: 521-534.
2. Trompezinski S, Denis A, Vinche A, Schmitt D, Viac J. IL-4 and interferon-gamma differentially modulate vascular endothelial growth factor release from normal human keratinocytes and fibroblasts. Exp Dermatol 2002: 11: 224-231.
3. Gharaee-Kermani M, Phan S H. Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr Pharm Des 2001: 7: 1083-1103.
4. Singer a J, Clark R A. Cutaneous wound healing. N Engl J Med 1999: 341: 738-746.
5. Dipietro L A, Burdick M, Low Q E, Kunkel S L, Strieter R M. MIP-1alpha as a critical macrophage chemoattractant in murine wound repair. J Clin Invest 1998: 101: 1693-1698.
6. Wang X P, Schunck M, Kallen K J et al. The interleukin-6 cytokine system regulates epidermal permeability barrier homeostasis. J Invest Dermatol 2004: 123: 124-131.
7. Matsumoto K, Robb E, Warden G, Nordlund J. The expression of cytokines, growth factors and ICAM-1 in the healing of human cutaneous xenografts on nude mice. Exp Dermatol 1997: 6: 13-21.
8. Stamm C, Westphal B, Kleine H D et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 2003: 361: 45-46.
9. Schachinger V, Erbs S, Elsasser A et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006: 355: 1210-1221.
10. Wollert K C, Meyer G P, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 2004: 364: 141-148.
11. Badiavas E V, Abedi M, Butmarc J, Falanga V, Quesenberry P. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol 2003: 196: 245-250.
12. Badiavas E V, Falanga V. Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 2003: 139: 510-516.
13. Tateishi-Yuyama E, Matsubara H, Murohara T et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: A pilot study and a randomised controlled trial. Lancet 2002: 360: 427-435.
14. Nakagawa H, Akita S, Fukui M, Fujii T, Akino K. Human mesenchymal stem cells successfully improve skin-substitute wound healing. Br J Dermatol 2005: 153: 29-36.
15. Suh W, Kim K L, Kim J M et al. Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells 2005: 23: 1571-1578.
16. Crosby J R, Kaminski W E, Schatteman G et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. Circ Res 2000: 87: 728-730.
17. Rehman J, Li J, Orschell C M, March K L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/ macrophages and secrete angiogenic growth factors. Circulation 2003: 107: 1164-1169.
18. Willert K, Brown J D, Danenberg E et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 2003: 423: 448-452.
19. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou a H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 2004: 10: 55-63.
20. Chenn A, Walsh C A. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 2002: 297: 365-369.
21. Templin C, Kotlarz D, Rathinam C et al. Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin. Exp Hematol 2008: 36: 204-215.
22. Templin C, Kotlarz D, Faulhaber J, Schnabel S, Grote K, Salguero G, Luchtefeld M, Hiller K H, Jakob P, Naim H Y, Schieffer B, Hilfiker-Kleiner D, Landmesser U, Limbourg F P, Drexler H. Ex Vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction: Role of beta-catenin transduction and cell dose. J Mol Cell Cardiol 2008: 45 (3): 394-403.
23. Escamez M J, Garcia M, Larcher F et al. An in vivo model of wound healing in genetically modified skin-humanized mice. J Invest Dermatol 2004: 123: 1182-1191.
24. Geer D J, Swartz D D, Andreadis S T. In vivo model of wound healing based on transplanted tissue-engineered skin. Tissue Eng 2004: 10: 1006-1017.
25. Wu Y, Chen L, Scott P G, Tredget E E. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007: 25 (10): 2648-2659.
26. Ong C T, Khoo Y T, Mukhopadhyay A et al. mTOR as a potential therapeutic target for treatment of keloids and excessive scars. Exp Dermatol 2007: 16: 394-404.
27. Kim W S, Park B S, Sung J H et al. Wound healing effect of adipose-derived stem cells: A critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci 2007: 48: 15-24.
28. Gnecchi M, He H, Noiseux N et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006: 20: 661-669.
29. Gnecchi M, He H, Liang O D et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005: 11: 367-368.
30. Kinnaird T, Stabile E, Burnett M S et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004: 109: 1543-1549.
31. Arnold F, West D C. Angiogenesis in wound healing. Pharmacol Ther 1991: 52: 407-422.
32. Martin P. Wound healing - aiming for perfect skin regeneration. Science 1997: 276: 75-81.
33. Hur J, Yoon C H, Kim H S et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 2004: 24: 288-293.